Company / Current Assets
AYTU BIOPHARMA, INC Current Assets History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$79.2M
FY2025
5-year range
$59.9M / $105.2M
FY2021-FY2025
Trend
+27.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 10 years, ranging from $3M in FY2017 to $105M in FY2021.
Based on SEC 10-K filings.
$79M in FY2025 with a 10-year CAGR of +25.7%.
Improved from $73M to $79M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +9.7%
- 5-Year CAGR
- +1.0%
- 10-Year CAGR
- +25.7%
Key checks
Key Insights
- 5-year CAGR of +1.0%, indicating consistent growth.
- In FY2025, current assets increased 27.9% year-over-year.
- Peak current assets was recorded in FY2021.
- Lowest current assets in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $79.2M | +27.9% |
| FY2024 | $61.9M | -15.0% |
| FY2023 | $72.8M | +21.5% |
| FY2022 | $59.9M | -43.1% |
| FY2021 | $105.2M | +39.5% |
| FY2020 | $75.4M | +696.4% |
| FY2018 | $9.5M | +212.7% |
| FY2017 | $3.0M | -70.1% |
| FY2016 | $10.1M | +25.8% |
| FY2015 | $8.0M | +431824.4% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026